Momentum will be offering a webinar entitled "Key Developments in Biosimilar Litigation" on March 11, 2015 from 1:00 to 2:00 pm (EDT). Louis E. Fogel, Paul D. Margolis, Steven R. Trybus of Jenner & Block will discuss the market for biosimilars and explore issues being considered by both innovators and companies who plan to bring biosimilars to the U.S. market. The panel will also explore arguments being made and considered in interpreting the Biologics Price Competition and Innovation Act (BPCIA), including a discussion of the key rulings, pending motions and arguments in the Amgen v. Sandoz cases relating to the BPCIA.
There is no fee for the webinar. Those interested in registering for the webinar, can do so here.
Comments